ILMN+93.66%29.0%
ONT.LSE-23.54%20.0%
PACB+7.33%18.0%
688114.SHG0.00%16.0%
TMO+21.82%7.0%
ROG.SW+19.13%6.0%
300676.SHE-25.40%4.0%
As of Jul 10, 2026, 7:14 AM ET
Genomics '25: Sequencing Hardware Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Roche Holding AGROG.SW | 6.0% | 0.00% | 0.15% | 0.08% | 0.32% | -5.05% | -17.66% | 20.82% | 19.13% | $312.89B |
Thermo Fisher Scientific Inc.TMO | 7.0% | 0.06% | 2.86% | 3.61% | 2.22% | -9.45% | 0.69% | 7.29% | 21.82% | $194.99B |
Illumina, Inc.ILMN | 29.0% | 1.50% | 3.17% | 6.99% | 5.37% | 47.73% | 44.10% | 136.64% | 93.66% | $29.32B |
—688114.SHG | 16.0% | 1.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $4.70B |
BGI Genomics Co., Ltd.300676.SHE | 4.0% | 4.20% | 1.45% | -3.20% | -5.70% | -21.14% | -27.80% | -30.23% | -25.40% | $2.14B |
Pacific Biosciences of California, Inc.PACB | 18.0% | 1.55% | 7.33% | -6.94% | -7.47% | -13.90% | -4.17% | 26.77% | 7.33% | $500.1M |
Oxford Nanopore Technologies plcONT.LSE | 20.0% | 2.27% | 4.30% | -1.31% | -8.17% | -7.93% | -11.28% | 17.51% | -23.54% | $15.5M |
| Theme return | — | 1.52% | 3.37% | 0.65% | 1.24% | 10.54% | 8.01% | 50.94% | 29.26% | — |
| Average | 14.3% | 1.53% | 2.75% | -0.11% | -1.92% | -1.39% | -2.30% | 25.54% | 13.29% | $77.79B |
| Median | 16.0% | 1.50% | 2.86% | 0.00% | 0.00% | -7.93% | -4.17% | 17.51% | 7.33% | $4.70B |
| Std Dev | 8.4% | 1.33% | 2.38% | 4.17% | 4.83% | 20.98% | 21.17% | 48.59% | 37.09% | $116.16B |
| Min | 4.0% | 0.00% | 0.00% | -6.94% | -8.17% | -21.14% | -27.80% | -30.23% | -25.40% | $15.5M |
| Max | 29.0% | 4.20% | 7.33% | 6.99% | 5.37% | 47.73% | 44.10% | 136.64% | 93.66% | $312.89B |
| % Positive Tickers | 85.71% | 85.71% | 42.86% | 42.86% | 14.29% | 28.57% | 71.43% | 57.14% |
About this theme
Genomics '25: Sequencing Hardware tracks 7 publicly listed stocks in this theme: 300676.SHE, 688114.SHG, ILMN, ONT.LSE, PACB, ROG.SW, TMO. See the constituent table for details.
